Abstract:Background/aims: Inflammatory bowel disease (IBD) is a common disease associated with disorders of the innate and adaptive immune response.Sulforaphane (SFN), a phytochemical in broccoli sprouts, is well known to have anti-inflammatory, antitumor and antioxidative properties.regulates activation of the innate immune system.We aimed to determine Sulforaphane alleviates dextran sodium sulfate (DSS)-induced inflammation through miR-155a in macrophages, and evaluated the miR-155 related mechanisms of Sulforaphane effects on inflammation and polarization in macrophage.Experimental approach: C57BL/6 mice received DSS (2%) in drinking water with 30 mg/kg intraperitoneal (i.p.) injection either 0.9% normal saline (NS) as control or SFN for 7 days.RAW264.7 cells were stimulated by lipopolysaccharide (LPS) and/or 20uM SFN for different hours to detect mRNA and protein levels.Results: We observed that SFN improved survival rate, reduced serum levels of pro-inflammatory cytokines IL-1β, IL-6, IL-18 and lowered histopathology scores after DSS-induced colitis.SFN affected the polarization status of intestinal macrophages evidenced by the increase of M2 marker Arg-1 and CD206 expression and the decrease of M1 marker iNOS and CD86 expression along with an increased Th2 cytokine IL-10 and decreased Th1 cytokine TNF-α in colon tissues and macrophages.Simultaneously, the inflammasome reduction of NLRP3 accompanied with increased polarization of phenotype resembling M2 macrophages.SFN markedly downregulated miR-155a in mouse colon and macrophages.As a target of miR-155, Quaking (QKI) is an inflammation-suppressor gene encoding a conserved RNA-binding protein.SFN reversed LPS-induced downregulation of QkI and QKI-dependent activated aryl hydrocarbon receptor (Ahr) expression both in mRNA and protein level.Introduction miR-155 expression in macrophages is induced by NF-kB and regulated by STATs.To identified how SFN regulates miR-155 in macrophages, We also analyzed NF-kB and STATs.SFN treatment inhibited phosphorylation of NF-κB p65 and STAT3 signal transducer, but enhanced STAT1 phosphorylation in LPS-induced macrophages.For further investigation, although Ahr was mediated by miR-155, Ahr responsed to negative feedback in NF-κB via form a complex with Stat1 and NF-κB p50 in LPS-induced macrophages after SFN stimulate.Ahr inhibited the NF-κB transcriptional activity and prolonged STAT1 activation.Conclusions: Our findings suggest that SFN protects DSS-induced colitis by switches macrophages polarization states in inflammation and defectives NLRP3 inflammasome activation.MiR-155 is a key regulator of Inhibiting proinflammatory for SFN treatment in macrophages.Ahr as a target of miR-155/QKI pathway also control S-491 AGA Abstracts and regulate Stat1/NF-κB/Ahr complex.Therefore, SFN might be a potential therapeutic agent for the treatment of IBD.

Prophylactic Effects of Sulforaphane on Depression-Like Behavior and Dendritic Changes in Mice after Inflammation

Antidepressant effects of sulforaphane (SFN) and its derivatives SLL-III-9 and SLL-III-120 and their potential underlying mechanisms based on the microbiota–gut–brain axis

The Efficacy and Safety of Sulforaphane As an Adjuvant in the Treatment of Bipolar Depressive Disorder

Sulforaphane activates anti-inflammatory microglia, modulating stress resilience associated with BDNF transcription

Protective Effect of Sulforaphane Against Depressive Behavior in Mice Through Glucocorticoid Receptor Antagonism

Sulforaphane Activates Brain-Derived Neurotrophic Factor (BDNF) Transcription by NF-E2-Related factor-2 (Nrf2), Showing Prevention Effects on the Microglial of Stressed Mice

Sulforaphane-Enriched Broccoli Sprouts Pretreated by Pulsed Electric Fields Reduces Neuroinflammation and Ameliorates Scopolamine-Induced Amnesia in Mouse Brain through Its Antioxidant Ability via Nrf2-HO-1 Activation

The Protective Effect of Sulforaphane on Dextran Sulfate Sodium-Induced Colitis Depends on Gut Microbial and Nrf2-Related Mechanism

Dietary sulforaphane glucosinolate mitigates depression-like behaviors in mice with hepatic ischemia/reperfusion injury: A role of the gut-liver-brain axis

Possible Prophylactic Effects of Sulforaphane on LPS-Induced Recognition Memory Impairment Mediated by Regulating Oxidative Stress and Neuroinflammatory Proteins in the Prefrontal Cortex Region of the Brain

Biological Mechanisms and Clinical Efficacy of Sulforaphane for Mental Disorders

Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-κB Inhibition and Nrf2/HO-1 Activation

Role of Keap1-Nrf2 Signaling in Depression and Dietary Intake of Glucoraphanin Confers Stress Resilience in Mice

Sulforaphane Attenuates AOM/DSS-Induced Colorectal Tumorigenesis in Mice via Inhibition of Intestinal Inflammation

Su1038 – Nod1 Deficient Gastric Stem Cells Fail to Differentiate to Parietal Cells and Cause Gastric Mucosal Atrophy

Inhibitory effects of sulforaphane on NLRP3 inflammasome activation

Sulforaphane Alleviates Lipopolysaccharide-induced Spatial Learning and Memory Dysfunction in Mice: the Role of BDNF-mTOR Signaling Pathway

The association of SOD and HsCRP with the efficacy of sulforaphane in schizophrenia patients with residual negative symptoms

Bioaccessible Organosulfur Compounds in Broccoli Stalks Modulate the Inflammatory Mediators Involved in Inflammatory Bowel Disease

Decreasing Risk Of Psychosis By Sulforaphane Study Protocol For A Randomized, Double-Blind, Placebo-Controlled, Clinical Multi-Centre Trial

Improving Insulin Resistance by Sulforaphane Via Activating the Bacteroides and Lactobacillus SCFAs-GPR-GLP1 Signal Axis.